Patent-Pending Platform Receives Government Validation Through Trademark Registration and $2M NSF Funding Invitation
“Every insight Womb WatchAI® generates answers questions decades of male-centric research couldn’t answer because they never bothered to ask,”— Quanda Francis
NEW YORK, NY, UNITED STATES, October 30, 2025 / EINPresswire.com / — WombWatchAI®, the world’s first bio-intent orchestration system powered by women’s biology, today announced it has secured federal trademark registration (Reg. No. 7,990,933, Class 44: Healthcare Services) on October 21, 2025, from the United States Patent and Trademark Office. The company also received an invitation from the National Science Foundation to submit a full proposal—potentially unlocking up to $2M in government funding. The milestones arrive as a rapidly growing community—tired of underfunded research, fragmented care, and systemic dismissal—prepares to launch Rhythm by WombWatchAI™, the first of eight products designed to transform women’s collective anger into undeniable evidence.
Between July 29 and October 28, 2025, engagement surged by 5,250%, signaling mobilization, not just interest.
“These numbers represent women who are done waiting,” said Quanda S. Francis, Founder and CEO. “They’re tired of being told their pain is ‘normal.’ Tired of research that excludes them. Tired of algorithms trained on male bodies. They’re not looking for another app—they’re looking for a weapon. WombWatchAI® is that weapon.”
The Problem: Systemic Dismissal by Design.
The healthcare system’s failure to serve women is structural: Women weren’t required in clinical drug trials until 1993. Algorithms, dosing protocols, and diagnostic criteria are based on 70kg male subjects. Black women face 3-4X higher maternal mortality rates. Endometriosis takes 7-10 years to diagnose. Erectile dysfunction receives 5X more funding than endometriosis research despite affecting fewer people.”For decades, they told us our hormones were ‘too complicated’ to study,” Francis said. “Translation: we weren’t worth the effort. Now we’re generating the data ourselves.”
The Solution: Bio-Intent Orchestration System™
Womb WatchAI ®’s proprietary Bio-Intent Orchestration System™ (patent pending) represents the first healthcare technology built exclusively on women’s biology, combining AI and quantum computing trained on female-specific biomarkers, Equity Lens technology with bias-detection algorithms addressing racial disparities, and crowdsourced research creating the evidence base that never existed. “Every insight Womb WatchAI® generates answers questions decades of male-centric research could